Full-Dose Heparin Best for Moderate COVID-19 Regardless of D-dimer

Full-dose prophylactic anticoagulation held substantial benefit for moderately ill COVID-19 patients regardless of initial D-dimer level, according to interim pooled results from the ACTIV-4a, ATTACC, and REMAP-CAP trials.